Mynzepli 40 mg/ml - Injektionslösung in einer Fertigspritze New

Recall | Medicines | 29/10/2026

The marketing authorisation holder informed its customers on October 29, 2026 that the mentioned batch is being recalled due to defective finger flanges on the pre-filled syringes.

Name of the medicinal product Mynzepli 40 mg/ml - Injektionslösung in einer Fertigspritze
Marketing authorisation number(s) EU/1/25/1964/002
CIP code 6060902
Marketing authorisation holder Advanz Pharma Limited
Batch number(s) 2325718
Expiry date 05/31/2027
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-5907
Email

Further inquiry note